Inventor

YANG DAJUN

CN33 patents

⚠️ This page may combine multiple inventors who share the name “YANG DAJUN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

YANG DAJUN

ASCENTAGE PHARMA SUZHOU CO LTD

MDM2 inhibitor and a platinum compound for cancer treatment

Combination product of BCL-2 inhibitor and MDM2 inhibitor and use thereof in the prevention and/or treatment of diseases

Pharmaceutical composition and use thereof

Combination of immunotherapies with MDM2 inhibitors

Synergistic antitumor effect of Bcl-2 inhibitor combined with rituximab and/or bendamustine or Bcl-2 inhibitor combined with CHOP

Combination product of Bcl-2 inhibitor and chemotherapeutic agent and use thereof in the prevention and/or treatment of diseases

Methods for cancer therapy

Pharmaceutical combination and use thereof

Pharmaceutical composition of MDM2 inhibitor and use thereof for preventing and/or treating disease

Combination product of a Bcl-2/Bcl-xL inhibitor and a chemotherapeutic agent and use thereof in the prevention and/or treatment of diseases

N-(phenylsulfonyl)benzamides and related compounds as Bcl-2 inhibitors

Pharmaceutical combination and use thereof

Combination of BCL-2/BCL-XL inhibitors and chemotherapeutic agent and use thereof

Compound for treating osteoarthritis

Method for treating cancer by combination of IAP inhibitor and modulator of immune checkpoint molecule

Combination product of Bcl-2 inhibitor or Bcl-2/Bcl-xL dual inhibitor and BTK inhibitor and use thereof in the prevention and/or treatment of diseases

Combination of Bcl-2/Bcl-xL inhibitors and chemotherapeutic agent and use thereof

Method and compositions for predicting anti-cancer efficacy of compounds targeting apoptosis pathway

Method for treating cancer by combination of FAK/ALK/ROS1 inhibitor and EGFR inhibitor

UNIV GEORGETOWN

Heregulin antagonists and methods for their use

Phenylalanine derivatives

ErbB-2 selective small molecule kinase inhibitors

Redox-stable, non-phosphorylated cyclic peptide inhibitors of SH2 domain binding to target protein, conjugates thereof, compositions and methods of synthesis and use

UNIV MICHIGAN

Small molecule antagonists of Bcl-2 family proteins

Small molecule inhibitors targeted at Bcl-2

Small molecule antagonists of XIAP family proteins

WANG SHAOMENG

Small molecule inhibitors of anti-apoptotic BCL-2 family members and the uses thereof

Small molecule antagonists of Bcl-2 family proteins

JIANGSU ASCENTAGE BIOMED DEV INC

Indoloquinolone compounds as anaplastic lymphoma kinase (ALK) inhibitors

Bisdiazabicyclo compound for treatment and/or prevention of hepatitis virus-related diseases or disorders

US HEALTH

Redox-stable, non-phosphorylated cyclic peptide inhibitors of SH2 domain binding to target protein, conjugates thereof, compositions and methods of synthesis and use

Phenylanine derivatives

UNIV GEORGETOWN MED CENTER

Small molecule inhibitors targeted at Bcl-2